RxDoctor Payments DataLook up a doctor →

ERZOFRI EXTENDED-RELEASE: payments to doctors

Payments that named ERZOFRI EXTENDED-RELEASE as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$301K
Providers
1,868
Transactions
3,208
Average per transaction
$94

The per-transaction average — $94 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 1,868 providers the average total is $161, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Luye Pharma (USA) Ltd.$300,711100.0%
← All drugs & devices